{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T21:44:27Z","timestamp":1766180667259,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,9,11]],"date-time":"2015-09-11T00:00:00Z","timestamp":1441929600000},"content-version":"vor","delay-in-days":467,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"St. Jude Medical and Siemens Healthcare"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.jcmg.2013.12.014","type":"journal-article","created":{"date-parts":[[2014,5,7]],"date-time":"2014-05-07T15:46:53Z","timestamp":1399477613000},"page":"561-569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["LGE and NT-proBNP Identify Low\u00a0Risk of Death or Arrhythmic Events in\u00a0Patients With Primary Prevention ICDs"],"prefix":"10.1016","volume":"7","author":[{"given":"Ify","family":"Mordi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pardeep S.","family":"Jhund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy S.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Payne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Carrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Berry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Tzemos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmg.2013.12.014_bib1","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2013.12.014_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2013.12.014_bib3","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1161\/01.CIR.0000150390.04704.B7","article-title":"Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator","volume":"110","author":"Moss","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2013.12.014_bib4","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jacc.2005.11.045","article-title":"Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study","volume":"47","author":"Stecker","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2013.12.014_bib5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10554-010-9726-9","article-title":"Myocardial scar extent evaluated by cardiac magnetic resonance imaging in ICD patients: relationship to spontaneous VT during long-term follow-up","volume":"27","author":"Bernhardt","year":"2011","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2013.12.014_bib6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCIMAGING.111.971549","article-title":"Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging","volume":"5","author":"Gao","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2013.12.014_bib7","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jacc.2010.06.062","article-title":"Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death","volume":"57","author":"Iles","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2013.12.014_bib8","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1161\/CIRCULATIONAHA.105.570648","article-title":"Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery\u00a0disease","volume":"113","author":"Kwong","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2013.12.014_bib9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCEP.110.959544","article-title":"The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in\u00a0patients with coronary artery disease\u00a0and implantable cardioverter-defibrillators","volume":"4","author":"Scott","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.jcmg.2013.12.014_bib10","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.jacc.2008.03.018","article-title":"Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy","volume":"51","author":"Wu","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2013.12.014_bib11","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.jacc.2006.07.049","article-title":"Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy","volume":"48","author":"Assomull","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2013.12.014_bib12","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/europace\/eur147","article-title":"Defining potential to benefit from implantable cardioverter defibrillator therapy: the role of biomarkers","volume":"13","author":"Scott","year":"2011","journal-title":"Europace"},{"key":"10.1016\/j.jcmg.2013.12.014_bib13","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/eurheartj\/ehr487","article-title":"Risk stratification of ischaemic patients with implantable cardioverter defibrillators by C-reactive protein and a multi-markers strategy: results of the Cami-Guide study","volume":"33","author":"Biasucci","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2013.12.014_bib14","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1161\/01.CIR.0000016642.15031.34","article-title":"B-type natriuretic peptide predicts sudden death in patients with chronic heart failure","volume":"105","author":"Berger","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2013.12.014_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/CIRCIMAGING.110.960450","article-title":"Bright-blood T2-weighted MRI has higher diagnostic accuracy than dark-blood short tau inversion recovery MRI for detection of acute myocardial infarction and for assessment of the ischemic area at risk and myocardial salvage","volume":"4","author":"Payne","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2013.12.014_bib16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejheart.2006.07.002","article-title":"A\u00a0change in N-terminal pro-brain natriuretic peptide is predictive of outcome in patients with advanced heart failure","volume":"9","author":"Gardner","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jcmg.2013.12.014_bib17","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable\u00a0defibrillator in advanced chronic heart\u00a0failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2013.12.014_bib18","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/01.CIR.74.6.1266","article-title":"Quantitative analysis of myocardial infarct structure in patients with ventricular tachycardia","volume":"74","author":"Bolick","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2013.12.014_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jcmg.2008.09.010","article-title":"Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study","volume":"2","author":"Kwon","year":"2009","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2013.12.014_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/CIRCIMAGING.108.826529","article-title":"Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with\u00a0ischemic cardiomyopathy and implantable cardioverter-defibrillator","volume":"2","author":"Roes","year":"2009","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2013.12.014_bib21","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1136\/heartjnl-2011-300060","article-title":"Scar size and characteristics assessed by CMR predict ventricular arrhythmias in ischaemic cardiomyopathy: comparison of previously validated models","volume":"97","author":"de Haan","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.jcmg.2013.12.014_bib22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/eurheartj\/ehi555","article-title":"Predictors of mortality and morbidity in patients with chronic heart failure","volume":"27","author":"Pocock","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2013.12.014_bib23","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","article-title":"State of the art: using natriuretic peptide levels in clinical practice","volume":"10","author":"Maisel","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jcmg.2013.12.014_bib24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/eurjhf\/hfn046","article-title":"Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide","volume":"11","author":"Wedel","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jcmg.2013.12.014_bib25","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jacc.2008.04.069","article-title":"Prognostic value of changes in N-terminal\u00a0pro-brain natriuretic peptide in Val-Heft (Valsartan Heart Failure Trial)","volume":"52","author":"Masson","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2013.12.014_bib26","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/eurjhf\/hfp123","article-title":"Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis","volume":"11","author":"Scott","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jcmg.2013.12.014_bib27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/hrt.2004.058198","article-title":"Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies","volume":"92","author":"Verma","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.jcmg.2013.12.014_bib28","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jacc.2009.11.029","article-title":"Evaluation of early complications related to de novo cardioverter defibrillator implantation insights from the Ontario ICD database","volume":"55","author":"Lee","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2013.12.014_bib29","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/CIRCIMAGING.111.968024","article-title":"Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low\u00a0risk for defibrillator firings and death","volume":"5","author":"Wu","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2013.12.014_bib30","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.amjcard.2005.11.048","article-title":"Frequency and causes of implantable cardioverter-defibrillator therapies: is device therapy proarrhythmic?","volume":"97","author":"Germano","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcmg.2013.12.014_bib31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jcmg.2010.11.015","article-title":"Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance","volume":"4","author":"Flett","year":"2011","journal-title":"J\u00a0Am Coll Cardiol Img"}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X1400237X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X1400237X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:40:35Z","timestamp":1761846035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X1400237X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1936878X1400237X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2013.12.014","relation":{},"ISSN":["1936-878X"],"issn-type":[{"type":"print","value":"1936-878X"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LGE and NT-proBNP Identify Low\u00a0Risk of Death or Arrhythmic Events in\u00a0Patients With Primary Prevention ICDs","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2013.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}